カテゴリ： MarketLine, オーストラリア, 企業調査

Dampier Gold Limited：企業の戦略・SWOT・財務分析

◆英語タイトル：Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4448
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：37
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：Metals and Mining
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Dampier Gold Limited – Strategy, SWOT and Corporate Finance Report
Summary

Dampier Gold Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Dampier Gold Limited (Dampier Gold) is a development stage mining company. It focuses on exploration of gold. Dampier Gold was established to acquire plutonic dome gold project from Barrick Gold Corporation. The company has mining assets in Archaean greenstone belt of Central Western Australia. The mine comprises advanced projects containing total mineral resource of 5.5 million tons (Mt) at 3.8gram per ton of gold for 682,800 contained ounces of gold. The company focuses on evaluating the potential for gold production. It has a plan to commence geological assessment, resource evaluation drilling and mining feasibility studies. Dampier Gold is headquartered in Queensland, Australia.

Scope

- Detailed information on Dampier Gold Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Dampier Gold Limited in the form of a SWOT analysis
- An in-depth view of the business model of Dampier Gold Limited including a breakdown and examination of key business segments
- Intelligence on Dampier Gold Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Dampier Gold Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Dampier Gold Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Dampier Gold Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Dampier Gold Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Dampier Gold Limited: Company Overview
Dampier Gold Limited: Overview and Key Facts
Dampier Gold Limited: Overview
Dampier Gold Limited: Key Facts
Dampier Gold Limited: Key Employees
Dampier Gold Limited: Key Employee Biographies
Dampier Gold Limited: Major Products and Services
Dampier Gold Limited: Company History
Dampier Gold Limited: Management Statement
Dampier Gold Limited: Key Competitors
Dampier Gold Limited: Company Analysis
Dampier Gold Limited: Business Description
Dampier Gold Limited: SWOT Analysis
Dampier Gold Limited: SWOT Overview
Dampier Gold Limited: Strengths
Dampier Gold Limited: Weaknesses
Dampier Gold Limited: Opportunities
Dampier Gold Limited: Threats
Dampier Gold Limited: Corporate Financial Deals Activity
Dampier Gold Limited: Financial Deals Overview
Dampier Gold Limited: Targets and Partners
Dampier Gold Limited: Top Deals 2016 – 2020YTD*
Dampier Gold Limited: Advisors
Dampier Gold Limited: Top Financial Advisors
Dampier Gold Limited: Mergers and Acquisitions
Dampier Gold Limited: Capital Raising
Dampier Gold Limited: Partnership
Dampier Gold Limited: Private Equity and Ownership
Dampier Gold Limited: Recent Developments
Dampier Gold Limited: News and Events Summary
Dampier Gold Limited: Corporate Governance
Dampier Gold Limited: Regulatory and Legal Events
Dampier Gold Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Dampier Gold Limited: Key Facts
Table 2: Dampier Gold Limited: Key Employees
Table 3: Dampier Gold Limited: Company History
Table 4: Dampier Gold Limited: Key Competitors
Table 5: Dampier Gold Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Dampier Gold Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Dampier Gold Limited: Targets and Partners
Table 8: Dampier Gold Limited: Top Deals 2016 - 2020YTD*
Table 9: Dampier Gold Limited: Financial Advisor Ranking by Value (US$m)
Table 10: Dampier Gold Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 11: Dampier Gold Limited: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Dampier Gold Limited: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Dampier Gold Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Dampier Gold Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Dampier Gold Limited: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 16: Dampier Gold Limited: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 17: Dampier Gold Limited: News and Events Summary
Table 18: Dampier Gold Limited: Corporate Governance
Table 19: Dampier Gold Limited: Regulatory and Legal Events
Table 20: Dampier Gold Limited: Strategy and Operations

★海外企業調査レポート[Dampier Gold Limited：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Glaukos Corp (GKOS)：企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Prosetta Biosciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein int …
  • Biolase Inc (BIOL)：医療機器：M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • Berkshire Hathaway Inc.：企業のM&A・事業提携・投資動向
    Berkshire Hathaway Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Berkshire Hathaway Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Storm Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Storm Therapeutics Ltd (Storm Therapeutics) a spin-out of University of Cambridge is focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer and other diseases. The company is engaged in modulating RNA modifying enzymes and is developing a unique …
  • GlobalSCAPE Inc (GSB)：企業の財務・戦略的SWOT分析
    Summary GlobalSCAPE Inc (GlobalSCAPE) is a technology company that offers secure information exchange solutions. The company offers EFT platform products such as EFT enterprise, EFT express, public and private cloud, collaboration, automation and efficiency, protocols, security, compliance and analy …
  • Debiopharm International SA-医療機器分野：企業M&A・提携分析
    Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for developmen …
  • Love’s Travel Stops & Country Stores Inc：企業の戦略・SWOT・財務情報
    Love’s Travel Stops & Country Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Love’s Travel Stops & Country Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Saskatchewan Power Corporation：発電所・企業SWOT分析
    Saskatchewan Power Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the opera …
  • GlaxoSmithKline Plc：企業のM&A・事業提携・投資動向
    GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Senomyx Inc (SNMX)：企業の財務・戦略的SWOT分析
    Summary Senomyx Inc (Senomyx) focuses on the discovery, development and commercialization of novel flavor ingredients and natural high intensity sweeteners (HIS) to packaged food, beverage and ingredient supply industries. The company discovers and develops novel flavor ingredients and natural HIS t …
  • Erytech Pharma SA (ERYP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • Caleres, Inc.：企業の戦略・SWOT・財務情報
    Caleres, Inc. - Strategy, SWOT and Corporate Finance Report Summary Caleres, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mitsui Oil Exploration Co Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary Mitsui Oil Exploration Co., Ltd. (MOECO), a subsidiary of Mitsui & Co., Ltd, is an upstream oil and gas company. The company explores for, develops and produces oil, natural gas and condensate from its assets. It is also involved in a geothermal energy project. The company also holds investm …
  • Alstom SA (ALO)-エネルギー分野：企業M&A・提携分析
    Summary Alstom SA (Alstom) is a manufacturer of transportation vehicles. It designs, develops and manufactures rail transport equipment, systems, services and signaling for urban, suburban, regional and main line passenger transportation, and for freight transportation. The company offers a wide ran …
  • Eguana Technologies Inc (EGT)：企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Vitasoy International Holdings Ltd.：企業の戦略・SWOT・財務分析
    Vitasoy International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vitasoy International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Epic Pharma LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug development company that manufactures and develops generic prescription drugs. The company’s products include amlodipine besylate, citalopram, betaxolol, nicardipine hydrochloride, guanfacine hydroch …
  • Schindler Holding Ltd (SCHP)：企業の財務・戦略的SWOT分析
    Schindler Holding Ltd (SCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆